Gainers
- Triple-S Management GTS shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is trading at a volume of 3.7 million, which is 7057.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $836.4 million.
- Reviva Pharmaceuticals RVPH shares moved upwards by 16.62% to $3.93. As of 12:30 EST, this security is trading at a volume of 2.3 million shares, making up 2066.86% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.6 million.
- Baudax Bio BXRX shares rose 15.99% to $0.61. As of 12:30 EST, Baudax Bio's stock is trading at a volume of 36.1 million, which is 1573.04% of its average full-day volume over the last 100 days. The company's market cap stands at $51.3 million.
- Bio-Path Holdings BPTH stock increased by 15.46% to $6.57. As of 12:30 EST, this security is trading at a volume of 58.7 million shares, making up 28637.33% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.7 million.
- GT Biopharma GTBP shares increased by 15.38% to $8.43. Trading volume for this security as of 12:30 EST is 426.7K, which is 126.77% of its average full-day volume over the last 100 days. The company's market cap stands at $178.2 million. As per the press release, Q2 earnings came out yesterday.
- XTL Biopharmaceuticals XTLB shares rose 13.73% to $4.72. The current volume of 164.9K shares is 125.62% of XTL Biopharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $24.9 million.
Losers
- Theravance Biopharma TBPH shares declined by 31.83% to $9.66 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 6.2 million, which is 1461.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $709.7 million.
- Vivos Therapeutics VVOS shares fell 14.5% to $5.04. As of 12:30 EST, this security is trading at a volume of 6.0 million shares, making up 200.08% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $115.0 million.
- ImmuCell ICCC shares fell 11.95% to $8.0. Trading volume for ImmuCell's stock is 52.5K as of 12:30 EST. This is 405.0% of its average full-day volume over the last 100 days. The company's market cap stands at $61.9 million.
- Generation Bio GBIO stock declined by 10.33% to $22.75. Trading volume for this security as of 12:30 EST is 235.4K, which is 70.04% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
- PolarityTE PTE shares decreased by 10.26% to $0.75. PolarityTE's stock is trading at a volume of 4.3 million shares as of 12:30 EST. This is 375.37% of its average full-day volume over the last 100 days. The company's market cap stands at $61.1 million.
- Evaxion Biotech EVAX shares decreased by 9.41% to $5.3. The market value of their outstanding shares is at $101.7 million.
BXRXBaudax Bio Inc Ordinary Shares
$0.0200-89.3%
EVAXEvaxion Biotech AS
$0.91771.10%
GBIOGeneration Bio Co
$1.07-2.73%
GTBPGT Biopharma Inc
$3.068.90%
ICCCImmuCell Corp
$4.944.88%
TBPHTheravance Biopharma Inc
$9.850.61%
VVOSVivos Therapeutics Inc
$4.72-7.87%
XTLBXTL Biopharmaceuticals Ltd
$1.73-1.70%
RVPHReviva Pharmaceuticals Holdings Inc
$1.788.55%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
